Date published: 2026-5-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

UBP 301 (CAS 569371-10-4)

0.0(0)
Write a reviewAsk a question

Alternate Names:
(αS)-α-Amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinepropanoic acid
Application:
UBP 301 is a kainate potent receptor antagonist
CAS Number:
569371-10-4
Purity:
≥98%
Molecular Weight:
459.2
Molecular Formula:
C15H14IN3O6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Available in US only.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

UBP 301 is a chemical compound that functions as a potent and selective inhibitor of a specific enzyme involved in cellular signaling pathways. It exerts its mechanism of action by binding to the active site of the enzyme, thereby preventing its normal function and disrupting downstream signaling cascades. This disruption ultimately leads to the modulation of various cellular processes, including gene expression, cell proliferation, and differentiation. UBP 301′s mechanism of action involves interfering with the enzyme′s ability to catalyze the conversion of its substrate, thereby altering the cellular response to various stimuli. Ubp 301′s function in experimental applications involves elucidating the specific roles of the targeted enzyme in cellular physiology. Its mechanism of action at the molecular level provides insights into the mechanisms governing cellular signaling and may contribute to the development for studying related pathways.


UBP 301 (CAS 569371-10-4) References

  1. Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists.  |  More, JC., et al. 2003. Br J Pharmacol. 138: 1093-100. PMID: 12684265
  2. Peripheral nerve injury increases glutamate-evoked calcium mobilization in adult spinal cord neurons.  |  Doolen, S., et al. 2012. Mol Pain. 8: 56. PMID: 22839304
  3. Rapid onset of a kainate-induced mirror focus in rat hippocampus is mediated by contralateral AMPA receptors.  |  Sobayo, T. and Mogul, DJ. 2013. Epilepsy Res. 106: 35-46. PMID: 23668947
  4. The utility of ionotropic glutamate receptor antagonists in the treatment of nociception induced by epidural glutamate infusion in rats.  |  Osgood, DB., et al. 2013. Surg Neurol Int. 4: 106. PMID: 24032081

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

UBP 301, 10 mg

sc-203716
10 mg
$388.00
US: Only available in the US

UBP 301, 50 mg

sc-203716A
50 mg
$1533.00
US: Only available in the US